| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,595,000 | 3,810,000 | 6,149,000 | 2,746,000 | | Cost of Revenue | 851,000 | 1,089,000 | 1,052,000 | 875,000 | | | Gross Profit | 744,000 | 2,721,000 | 5,097,000 | 1,871,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 359,000 | 393,000 | 640,000 | 722,000 | | Non Recurring | 51,000 | 156,000 | 56,000 | 11,000 | | Others | 806,000 | 756,000 | 844,000 | 744,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (472,000) | 1,416,000 | 3,557,000 | 394,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 108,000 | (56,000) | (22,000) | 14,000 | | Earnings Before Interest And Taxes | (364,000) | 1,352,000 | 3,525,000 | 403,000 | | Interest Expense | 181,000 | 184,000 | 180,000 | 151,000 | | Income Before Tax | (545,000) | 1,168,000 | 3,345,000 | 252,000 | | Income Tax Expense | (214,000) | 387,000 | 1,181,000 | 236,000 | | Minority Interest |
-
| (8,000) | (10,000) | (5,000) | | | | Net Income From Continuing Ops | (331,000) | 781,000 | 2,164,000 | 16,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 5,000 | 1,000 | 7,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (331,000) | 786,000 | 2,165,000 | 23,000 | | Preferred Stock And Other Adjustments | (7,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($338,000) | $786,000 | $2,165,000 | $23,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
